Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Gustave Roussy, Cancer Campus, Grand Paris
University of Oxford
University of Illinois at Chicago
Intergroupe Francophone de Cancerologie Thoracique
Mario Negri Institute for Pharmacological Research
The Cleveland Clinic
City of Hope Medical Center
University of Rochester
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Shanghai Chest Hospital
Spanish Lung Cancer Group
University of Nebraska
AIO-Studien-gGmbH
Assistance Publique Hopitaux De Marseille
Second Affiliated Hospital of Soochow University
Odense University Hospital
University Hospital, Brest
Wales Cancer Trials Unit
Vejle Hospital
Shanghai Pulmonary Hospital, Shanghai, China
Shanghai Chest Hospital
University of Turin, Italy
Sungkyunkwan University
Guangdong Association of Clinical Trials
Hunan Province Tumor Hospital
International Group of Endovascular Oncology
Samsung Medical Center
Shanghai University of Traditional Chinese Medicine
Thoraxklinik-Heidelberg gGmbH
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Shenzhen People's Hospital
Memorial Sloan Kettering Cancer Center
Western Regional Medical Center
Medical University of South Carolina
University Hospital, Limoges
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Alliance for Clinical Trials in Oncology
H. Lee Moffitt Cancer Center and Research Institute
Yonsei University
Xinqiao Hospital of Chongqing
Tianjin Medical University Cancer Institute and Hospital
Hellenic Oncology Research Group
Alliance for Clinical Trials in Oncology
University of Southern California
Intergroupe Francophone de Cancerologie Thoracique
Aktion Bronchialkarzinom e.V.
National Cancer Institute, Naples
National Cancer Institute, Naples